Literature DB >> 4015212

The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients.

C K McSherry, H Ferstenberg, W F Calhoun, E Lahman, M Virshup.   

Abstract

The natural history of gallstone disease in 691 patients, followed for a mean +/- SD duration of 78 +/- 61.6 months (median 62.9 months), is presented. These patients are all subscribers of a large health maintenance organization and are believed to represent a cross-section of middle income Americans. Symptoms attributed to biliary tract disease were present in 556 (80.5%), and the other 135 (19.5%) patients were asymptomatic. In the symptomatic group, the mean +/- SD duration of observation was 82.9 +/- 63.2 months (median 68.5 months); 242 (44%) eventually underwent biliary tract operations most often because of persistent symptoms. Only 10% of asymptomatic patients followed for 58 +/- 50.2 months (median 46.3 months) developed symptoms of biliary calculi, and seven per cent required operations. There were 50 deaths in this series of 691 patients, 25 in the symptomatic group, and 25 in the asymptomatic. Only two of these deaths were biliary tract related, and both were in the symptomatic group. This study suggests that patients with silent stones do not need to be operated on prior to the development of symptoms. In addition, many patients with symptoms of biliary calculi can tolerate their symptoms for long periods of time and prefer this course of action to cholecystectomy.

Entities:  

Mesh:

Year:  1985        PMID: 4015212      PMCID: PMC1250837          DOI: 10.1097/00000658-198507000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  Surgical indications in cholelithiasis: prophylactic choleithiasis: prophylactic cholecystectomy elucidated on the basis of long-term follow up on 526 nonoperated cases.

Authors:  J LUND
Journal:  Ann Surg       Date:  1960-02       Impact factor: 12.969

2.  The Silent Gallstone: A Ten to Twenty Year Follow-up Study of 112 Cases.

Authors:  M W Comfort; H K Gray; J M Wilson
Journal:  Ann Surg       Date:  1948-11       Impact factor: 12.969

3.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

4.  The incidence and causes of death following surgery for nonmalignant biliary tract disease.

Authors:  C K McSherry; F Glenn
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

5.  The National Cooperative Gallstone Study report: a surgeon's perspective.

Authors:  C K McSherry
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

6.  The natural course of gallstone disease: eleven-year review of 781 nonoperated cases.

Authors:  A Wenckert; B Robertson
Journal:  Gastroenterology       Date:  1966-03       Impact factor: 22.682

7.  The natural history of silent gallstones: the innocent gallstone is not a myth.

Authors:  W A Gracie; D F Ransohoff
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

Review 8.  Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.

Authors:  L J Schoenfield; J M Lachin
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

  8 in total
  71 in total

1.  A 5-year review of carotid endarterectomy in a vascular unit using a computerised audit system.

Authors:  T R Magee; J J Earnshaw; S E Cole; J K Hayward; R N Baird; M Horrocks
Journal:  Ann R Coll Surg Engl       Date:  1992-11       Impact factor: 1.891

2.  Which Abdominal Symptoms are Associated with Clinical Events in a Population Unaware of Their Gallstones? a Cohort Study.

Authors:  Daniel Mønsted Shabanzadeh; Lars Tue Sørensen; Torben Jørgensen
Journal:  J Gastrointest Surg       Date:  2017-01-12       Impact factor: 3.452

3.  The risk paradox: use of elective cholecystectomy in older patients is independent of their risk of developing complications.

Authors:  Taylor S Riall; Deepak Adhikari; Abhishek D Parmar; Suzanne K Linder; Francesca M Dimou; Winston Crowell; Nina P Tamirisa; Courtney M Townsend; James S Goodwin
Journal:  J Am Coll Surg       Date:  2014-12-17       Impact factor: 6.113

4.  Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation.

Authors:  Roshan Shrestha; David M S Grunkemeier
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

Review 5.  Appropriateness of cholecystectomy in the United Kingdom--a consensus panel approach.

Authors:  E A Scott; N Black
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.

Authors:  A Sonnenberg; G A Derfus; K H Soergel
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

7.  Incidental cholecystectomy during colorectal surgery.

Authors:  E S Juhasz; B G Wolff; A P Meagher; R M Kluiber; A L Weaver; J A van Heerden
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

8.  Usefulness of gallbladder ejection fraction estimation to predict the recurrence of biliary pain in patients with symptomatic gallstones who did not undergo cholecystectomy.

Authors:  Sung Noh Hong; Jong Kyun Lee; Kyu Taek Lee; Jin Seok Heo; Seong Ho Choi; Poong Lyul Rhee; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

9.  Twenty years after Erich Muhe: Persisting controversies with the gold standard of laparoscopic cholecystectomy.

Authors:  Kalpesh Jani; P S Rajan; K Sendhilkumar; C Palanivelu
Journal:  J Minim Access Surg       Date:  2006-06       Impact factor: 1.407

10.  Is complicated gallstone disease preceded by biliary colic?

Authors:  Marc G Besselink; Niels G Venneman; Peter M Go; Ivo A Broeders; Peter D Siersema; Hein G Gooszen; Karel J van Erpecum
Journal:  J Gastrointest Surg       Date:  2008-10-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.